DOI:
10.1055/s-00043364
Pharmaceutical Fronts
LinksClose Window
References
Mita MM, Joy AA, Mita A. et al.
Randomized phase II trial of the cyclin-dependent kinase inhibitor dinaciclib (MK-7965) versus capecitabine in patients with advanced breast cancer.
Clin Breast Cancer 2014;
14 (03) 169-176
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.